Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04499924 |
|---|---|
| Brief Title: | Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer (MOUNTAINEER-02) |
| First Submitted : | July 31, 2020 |
| First Submitted that Met QC Criteria : | July 31, 2020 |
| First Posted : | August 5, 2020 |
| Last Update Submitted that Met QC Criteria : | August 28, 2023 |
| Last Update Posted : | August 29, 2023 |